- Become a Member
- Log in
Do not miss this webinar on Thursday, April 2nd with Ken Xiong, Senior Manager of Innovation Collaboration, Merck Innovation Hub China. We will discuss how to reinvent healthcare through AI.
Ken Xiong, Senior Manager of Innovation Collaboration, Merck Innovation Hub China
Ken Xiong is responsible for scouting the best science and technology start-ups to collaborate with and invest in, and foresight of innovation field for Merck China Innovation Hub. Before this, he was working in the VC arm of Fosun Pharma to invest in global innovation-driven start-ups in healthcare sector. Meanwhile, he was also experienced in technology transfer and incubation. He is a biologist by training and holds a PhD degree of Oncology from Sun Yat-sen University. He also attended a joint PhD program of Harvard Medical School, and got trained at Brigham and Women’s Hospital in Boston.
The objective of the Accelerator program is to identify promising startups, connect them to relevant business sectors and build pilot projects to foster to innovation projects of Merck and its three business sectors for co-development and a sustainable business partnership. With focus on startups in the seed to series A financing round in the fields of healthcare, performance materials, life sciences, AI enabled health solutions, organoid, bioelectronics, liquid biopsy, neuromorphic system and clean meat.
The application for the third intake of China Accelerator program is open from March 3, 2020 until March 31, 2020. Apply now at 'Read more' at the bottom left of this article.
As an important part of Merck’s global innovation network, the China Innovation Hub scouts, incubates and invests in innovative opportunities in healthcare, life science, performance materials and related fields between and beyond the existing businesses. Embedded into China’s innovation ecosystem, Merck Innovation Hub China is committed to partnering with start-ups, academic institutions, industry players and local governments, combining unique technology and expertise from Merck Group and collaborators with the goal to develop novel technology and bring new solutions to the market for China and global. The China Innovation Hub also provides support of ideation, incubation and trainings to local talents, partners and Merck employees to build win-win collaboration. For more information, please visit http://innovateinchina.merckgroup.com.
Merck China Innovation Center
Senior Manager of Innovation Collaboration
Ken Xiong, Senior Manager at Merck China Innovation Center. Ken is responsible for selecting the best technology start-ups and cooperating with Merck China Innovation Center to invest in innovation. Prior to that, he worked in the venture capital department of Fosun Pharma, investing in global innovation-driven healthcare start-ups. Ken is also very experienced in technology transfer and incuba...